U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07210671) titled 'PROSPECTIVE EVALUATION OF THE TREATMENT OF CANCER- ASSOCIATED SUPERFICIAL VENOUS' on Sept. 30.
Brief Summary: Superficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials for DVT. There is therefore no high-level evidence-based treatment recommendation for these patients. Recent data suggest that the course of cancer-associated DVT is similar to that of cancer-associated deep vein thrombosis (DVT). However, there are currently few prospective data on the evolution of cancer-associated DVT in rela...